Bio Path Holdings Inc reports results for the quarter ended in March - Earnings Summary

Bio Path Holdings

14/05/2021 14:32

* Bio Path Holdings Inc  BPTH.OQ  reported a quarterly adjusted
loss of 43 cents​​ per share for the quarter ended in March. The
mean expectation of two analysts for the quarter was for a loss
of 49 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* The mean earnings estimate of analysts had risen by about 34%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Bio Path Holdings Inc shares had fallen by 26.9% this
quarter and gained 46.6% so far this year.
* Wall Street's median 12-month price target for Bio Path
Holdings Inc is $12.50 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 14 at 01:32 p.m. GMT.
​All figures in US dollars